0001397702-21-000039.txt : 20210518 0001397702-21-000039.hdr.sgml : 20210518 20210518160338 ACCESSION NUMBER: 0001397702-21-000039 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20210513 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant FILED AS OF DATE: 20210518 DATE AS OF CHANGE: 20210518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Silk Road Medical Inc CENTRAL INDEX KEY: 0001397702 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 208777622 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38847 FILM NUMBER: 21935934 BUSINESS ADDRESS: STREET 1: 1213 INNSBRUCK DR. CITY: SUNNYVALE STATE: CA ZIP: 94089-2918 BUSINESS PHONE: 6505669060 MAIL ADDRESS: STREET 1: 1213 INNSBRUCK DR. CITY: SUNNYVALE STATE: CA ZIP: 94089-2918 8-K 1 silk-20210513x8k.htm 8-K silk-20210513x8k
false000139770200013977022021-05-132021-05-13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________________

FORM 8-K

____________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 13, 2021

____________________________

SILK ROAD MEDICAL, INC.

(Exact name of Registrant as specified in its charter)

____________________________

Delaware

001-38847

20-8777622

(State or other jurisdiction of
incorporation or organization)

(Commission
File Number)

(I.R.S. Employer
Identification Number)

1213 Innsbruck Drive

Sunnyvale, California 94089

(Address of principal executive office) (Zip Code)

(408) 720-9002

(Registrant’s telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, Par Value $0.001 Per Share

SILK

The NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2) of this chapter

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 1.01. Entry into a Material Definitive Agreement.

On May 13, 2021, Silk Road Medical, Inc. (the “Company”) entered into a Lease (the “Lease Agreement”) with ARHC UHPTHMN01, LLC (the “Landlord”).

 

Pursuant to the Lease Agreement, the Company will lease approximately 63,000 square feet located at 14755 27th Avenue North, Plymouth, MN 55447 (the “Premises”). The Company expects to house office space, distribution, warehouse, and manufacturing space on the Premises. The buildout for the Premises will begin at once, with completion and occupancy scheduled for late November 2021.

 

The Term of the Lease Agreement is approximately 8.5 years (the “Initial Term”), with the option of two 5-year renewals.

 

Under the terms of the Lease Agreement, the Company’s initial annual base rent will be approximately $0.8 million and increased on each anniversary of the Lease Commencement Date by two and a half percent (2.5%). The Landlord will also provide an allowance of approximately $1.6 million related to building improvements set forth in the Lease Agreement.

 

This summary of the Lease Agreement does not purport to be complete and is subject to, and qualified in its entirety by reference to the Lease Agreement, a copy of which will be filed in the Company’s next quarterly report on Form 10-Q. Capitalized terms used above without definition are defined in the Lease Agreement.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information required by this Item 2.03 is as set forth in Item 1.01 — Entry into a Material Definitive Agreement above and incorporated by reference.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SILK ROAD MEDICAL, INC.

Date: May 18, 2021

By:

/s/ Erica J. Rogers

Erica J. Rogers

President, Chief Executive Officer and Director

EX-101.SCH 2 silk-20210513.xsd EX-101.SCH 00090 - Document - Document And Entity Informationlink:presentationLinklink:calculationLinklink:definitionLink EX-101.LAB 3 silk-20210513_lab.xml EX-101.LAB Document And Entity Information [Abstract] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity File Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Amendment Flag EX-101.PRE 4 silk-20210513_pre.xml EX-101.PRE XML 5 silk-20210513x8k_htm.xml IDEA: XBRL DOCUMENT 0001397702 2021-05-13 2021-05-13 false 0001397702 8-K 2021-05-13 SILK ROAD MEDICAL, INC. DE 001-38847 20-8777622 1213 Innsbruck Drive Sunnyvale CA 94089 408 720-9002 false false false false Common Stock, Par Value $0.001 Per Share SILK NASDAQ false XML 6 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Document And Entity Information
May 13, 2021
Document And Entity Information [Abstract]  
Document Type 8-K
Document Period End Date May 13, 2021
Entity Registrant Name SILK ROAD MEDICAL, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-38847
Entity Tax Identification Number 20-8777622
Entity Address, Address Line One 1213 Innsbruck Drive
Entity Address, City or Town Sunnyvale
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94089
City Area Code 408
Local Phone Number 720-9002
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, Par Value $0.001 Per Share
Trading Symbol SILK
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001397702
Amendment Flag false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 1 95 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://silkroadmed.com/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports silk-20210513x8k.htm silk-20210513.xsd silk-20210513_lab.xml silk-20210513_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "silk-20210513x8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "silk-20210513x8k.htm" ] }, "labelLink": { "local": [ "silk-20210513_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "silk-20210513_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "silk-20210513.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "silk", "nsuri": "http://silkroadmed.com/20210513", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "silk-20210513x8k.htm", "contextRef": "Duration_5_13_2021_To_5_13_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document And Entity Information", "role": "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "silk-20210513x8k.htm", "contextRef": "Duration_5_13_2021_To_5_13_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document And Entity Information [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://silkroadmed.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001397702-21-000039-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001397702-21-000039-xbrl.zip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end